Navigation Links
A new indicator for esophageal varix in alcoholic disease
Date:5/20/2008

= 0.017). The area under the curve of type IV collagen, as determined by the receiver operating characteristic for predicting expressed esophageal varices, was 0.78.

The combination of abdominal ultrasound scan and type IV collagen correctly identified, at a high rate, the patients with esophageal varices.


'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Research highlights important indicators of early-stage ovarian cancer
2. Hospital quality indicator may not be linked to patient survival after colon cancer surgery
3. The American Nurses Association Hosts Conference on the National Database of Nursing Quality Indicators
4. Low levels of PYY hormone a very early indicator of type 2 diabetes
5. Diabetes Ten City Challenge Collaborative Model Shows Improved Patient Health Across Key Clinical Indicators
6. Impaired sense of smell may be early indicator of Parkinsons disease
7. Data Dimensions Assists Clients With Compliance of Present on Admission (POA) Indicator Reporting Requirements as Part of the April 1, 2008 Timeline
8. The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers
9. Married esophageal cancer patients fare worse in some quality of life aspects than single patients
10. Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry
11. Obesity Boosts Esophageal Cancer Risk

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...y Auction Company, Exclusively Auctions AZ, will s...unity of Cherry Hills Village, Denver, CO, by Abso... Denver, Colo. (PRWEB) November 23, 2009 -...ess, located in Cherry Hills Village in Denver, Co... no details were overlooked. Ms. Fentress is the d...
(Date:11/22/2009)...essel growth has now been found to be responsible ...ps that characterize one of the most severe forms ... suggests. The finding gives scientists a new targ...rm of the disease, which typically resists all cur... irritation and swelling of the nasal passages, is...
(Date:11/22/2009)... -- When people have malaria, they are infected wi... the saliva of a mosquito, infect cells in the liv... blood cells, the parasites replicate and also beg... that change the physical nature of the cells in t... red blood cells are stiffer and stickier than nor...
(Date:11/22/2009)... an innovative healthcare benefit solutions compan...ted a recapitalization with Silver Point Capital, ...r Point Capital, L.P. is a private investment firm...zation allows the Company to continue its growth a... (PRWEB) November 22, 2009 -- Healt...
(Date:11/21/2009)...swire-USNewswire/ -- DNC Chairman Tim Kaine issued... begin full debate of health insurance reform legi...-bin/prnh/20080519/DNCLOGO ) ,, "Today, the S...acting health insurance reform. By clearing this f...opportunity to debate the health reform bill on th...
Breaking Medicine News(10 mins):Health News:Barbara Fentress, Designer of the Denver International Airport and Convention Center, Offers Her Private Mansion at Absolute Auction 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 2Health News:Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps 3Health News:Measuring and modeling blood flow in malaria 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2
...ka Academy, University of Gothenburg, Sweden, conc...suicide attempt are five times more likely to atte...have nightmares. , The study included 165 patient...lf-assessments were carried out as part of the stu...
...d research plays a significant role in African-Ame...according to a study by researchers at Children,s ...of Pittsburgh Graduate School of Public Health. ,... & Adolescent Medicine addresses the racial diffe...
...ffices further Covance,s geographic reach, expand ...3 Covance Inc. (NYSE: CVD ), one of the world,s...ervices companies, today announced the opening of ... , , Covance has been providing clinical trial s...
... an issue vexing the health system worldwide the ...ic health records.,Working through the Australian ...s have developed software that will be used to sta...lth records will only improve patient safety and o...
...onmental Factors Trump Genetics in Facial Aging , ...wrinkles -- or lack there of, may not be the best ...claims just the opposite. The study, involving ide...n the web-based version of Plastic and Reconstruct...
...ter for Association Resources, an,association mana...tions,located in the Chicago area, is pleased to a...ution to be used by one of its clients in the,heal...CTV. , "We,re excited about this additional re...
Other Medicine News:Health News:Nightmares increase risk of further suicide attempts 2Health News:Children's Hospital study finds African-Americans more distrusting of research than whites 2Health News:Children's Hospital study finds African-Americans more distrusting of research than whites 3Health News:Covance Opens Three New Offices in Ukraine, Slovakia, and Israel 2Health News:Covance Opens Three New Offices in Ukraine, Slovakia, and Israel 3Health News:Australian technology in global health toolkit 2Health News:Divorce, Antidepressants, or Weight Gain/Loss Can Add Years to Your Face 2Health News:Center for Association Resources Launches E-Learning Service 2
(Date:11/20/2009)... , NEW YORK, Nov. 20 Repor...eport is available in its catalogue. ,, Global..., http://www.reportlinker.com/p0164742/Global...ml#utm_source=prnewswire&utm_medium=pr&utm...sisted Reproduction covers the U.S., 15 Countries ...
(Date:11/20/2009)... , NATICK, Mass. and LONDON, Nov. 20 /PRNewsw...YSE: BSX ) today announced that it has received ...istration (FDA) and CE Mark approval to market its... the treatment of malignant esophageal strictures ...esectable or non-resectable esophageal cancer. ,...
(Date:11/20/2009)... , HOUSTON, Nov. 20 /PRNewswire-FirstCall/ -...d that Dan Moore, President and Chief Executive Of...ill present at the 21st Annual Piper Jaffray Healt...er 2, 2009 at 12:00 PM EST. The conference sessio...des will be presented. Piper Jaffray will host a ...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Cynosure Reports Third Quarter 2009 Financial Results 14605 1Cynosure Reports Third Quarter 2009 Financial Results 14605 2Cynosure Reports Third Quarter 2009 Financial Results 14605 3Cynosure Reports Third Quarter 2009 Financial Results 14605 4Cynosure Reports Third Quarter 2009 Financial Results 14605 5Cynosure Reports Third Quarter 2009 Financial Results 14605 6Cynosure Reports Third Quarter 2009 Financial Results 14605 7Cynosure Reports Third Quarter 2009 Financial Results 14605 8Cynosure Reports Third Quarter 2009 Financial Results 14605 9Cynosure Reports Third Quarter 2009 Financial Results 14605 10Cynosure Reports Third Quarter 2009 Financial Results 14605 11Cynosure Reports Third Quarter 2009 Financial Results 14605 12Boston Medical Center Managing H1N1 Flu Vaccination for its Community with Carefxs New Immunization Management Solution 5734 1Boston Medical Center Managing H1N1 Flu Vaccination for its Community with Carefxs New Immunization Management Solution 5734 2Boston Medical Center Managing H1N1 Flu Vaccination for its Community with Carefxs New Immunization Management Solution 5734 3Hospira Reports Third Quarter 2009 Results 5729 1Hospira Reports Third Quarter 2009 Results 5729 2Hospira Reports Third Quarter 2009 Results 5729 3Hospira Reports Third Quarter 2009 Results 5729 4Hospira Reports Third Quarter 2009 Results 5729 5Hospira Reports Third Quarter 2009 Results 5729 6Hospira Reports Third Quarter 2009 Results 5729 7Hospira Reports Third Quarter 2009 Results 5729 8Hospira Reports Third Quarter 2009 Results 5729 9Hospira Reports Third Quarter 2009 Results 5729 10Hospira Reports Third Quarter 2009 Results 5729 11Hospira Reports Third Quarter 2009 Results 5729 12Hospira Reports Third Quarter 2009 Results 5729 13Hospira Reports Third Quarter 2009 Results 5729 14Hospira Reports Third Quarter 2009 Results 5729 15Hospira Reports Third Quarter 2009 Results 5729 16Hospira Reports Third Quarter 2009 Results 5729 17Hospira Reports Third Quarter 2009 Results 5729 18Hospira Reports Third Quarter 2009 Results 5729 19Hospira Reports Third Quarter 2009 Results 5729 20Hospira Reports Third Quarter 2009 Results 5729 21Hospira Reports Third Quarter 2009 Results 5729 22Hospira Reports Third Quarter 2009 Results 5729 23Hospira Reports Third Quarter 2009 Results 5729 24Hospira Reports Third Quarter 2009 Results 5729 25Hospira Reports Third Quarter 2009 Results 5729 26Hospira Reports Third Quarter 2009 Results 5729 27Hospira Reports Third Quarter 2009 Results 5729 28
...gesX, Inc.,(Nasdaq: NGSX ) announced today that i... Phase 3 clinical trial of its lead product candid...al sensory polyneuropathy,(HIV-DSP). NGX-4010 is a...athic pain. Previously completed Phase 3 trials de...nt with NGX-4010 applied directly to the,site of p...
..., a,licensee of Vical Incorporated (Nasdaq: VICL ...ient Phase 3 clinical trial of its NV1FGF,angiogen...DNA delivery,technology. Assuming successful compl...expects to file for marketing approval in 2010. T...rowth Factor 1,(FGF-1), a growth factor that stimu...
Other Medicine Technology:NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 2NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 3NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy 4Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations 2Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations 3
...SAPORT™ RT cannulas are all able to be used ...th the RT system. , ,The VERSAPORT™ RT cann...r systems packaged for use with the RT system. The...PORT™ Plus V2, SURGISPIKE™ (5mm only, ...
...SAPORT™ PLUS V2 trocar has a sharp linear bl...to Suture™ VERSAPORT™ PLUS V2 trocar i...mm-12 mm long sizes with a radiolucent sleeve and ...sharp linear blade and a spring-loaded locking shi...
...o Suture™ SPRING-GRIP™ single use nonc... 10 mm, 11 mm and 12 mm sizes for use with the SUR...0 mm, 5 mm-11 mm, 5 mm-12 mm and 10 mm-15 mm sizes...de;, PREMIUM SURGIPORT™, SURGIPORT™ II...
...plete line of Surgical Access ...unlike any trocar...ocar system is actually four systems in one desig...inically adaptive to all of your needs., ,By offe...ng tip styles, OnePort™ can effectively addr...
Medicine Products: